Financhill
Sell
37

MTVA Quote, Financials, Valuation and Earnings

Last price:
$9.59
Seasonality move :
-5.96%
Day range:
$8.49 - $9.68
52-week range:
$6.05 - $30.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
37.35x
Volume:
81.5K
Avg. volume:
371.3K
1-year change:
-63.28%
Market cap:
$236.5M
Revenue:
--
EPS (TTM):
-$11.34

Analysts' Opinion

  • Consensus Rating
    MetaVia, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $132.00, MetaVia, Inc. has an estimated upside of 1317.83% from its current price of $9.31.
  • Price Target Downside
    According to analysts, the lowest downside price target is $55.00 representing -490.76% downside risk from its current price of $9.31.

Fair Value

  • According to the consensus of 2 analysts, MetaVia, Inc. has 1317.83% upside to fair value with a price target of $132.00 per share.

MTVA vs. S&P 500

  • Over the past 5 trading days, MetaVia, Inc. has overperformed the S&P 500 by 14.5% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • MetaVia, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • MetaVia, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter MetaVia, Inc. reported revenues of --.

Earnings Growth

  • MetaVia, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter MetaVia, Inc. reported earnings per share of -$1.52.
Enterprise value:
222.3M
EV / Invested capital:
34.68x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-13.66x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$23K
Return On Assets:
-96.8%
Net Income Margin (TTM):
--
Return On Equity:
-196.71%
Return On Invested Capital:
-193.95%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -$3K -$19K -$23K -$5K -$5K
Operating Income -$12.4M -$28.9M -$17.2M -$6.3M -$3.5M
EBITDA -$12.4M -$28.9M -$17.2M -$6.3M -$3.5M
Diluted EPS -$2.88 -$4.77 -$11.34 -$0.55 -$1.52
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $7.8M $7.2M $26.1M $21.9M $14.6M
Total Assets $8.1M $7.6M $26.4M $22.1M $14.8M
Current Liabilities $1.9M $1.6M $4.7M $9.1M $8.4M
Total Liabilities $2M $1.6M $4.9M $9.2M $8.4M
Total Equity $6.1M $5.9M $21.6M $13M $6.3M
Total Debt $51K -- $153K $79K --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$9.2M -$22.7M -$16.3M -$5.6M -$3M
Cash From Investing -$41K -$17K -$2K -- --
Cash From Financing $28.7M $18.5M $8.9M -$676K -$357K
Free Cash Flow -$9.3M -$22.7M -$16.3M -$5.6M -$3M
MTVA
Sector
Market Cap
$236.5M
$28.6M
Price % of 52-Week High
30.78%
51.66%
Dividend Yield
0%
0%
Shareholder Yield
-3.56%
-1.34%
1-Year Price Total Return
-63.28%
-20.19%
Beta (5-Year)
0.286
0.519
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $8.71
200-day SMA
Sell
Level $9.87
Bollinger Bands (100)
Buy
Level 6.99 - 11.09
Chaikin Money Flow
Buy
Level 3.9M
20-day SMA
Buy
Level $8.28
Relative Strength Index (RSI14)
Buy
Level 52.08
ADX Line
Buy
Level 20.33
Williams %R
Neutral
Level -55.7667
50-day SMA
Sell
Level $9.69
MACD (12, 26)
Sell
Level -0.08
25-day Aroon Oscillator
Buy
Level 12
On Balance Volume
Neutral
Level 18.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-3.0749)
Sell
CA Score (Annual)
Level (-6.5198)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (10.8873)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

Stock Forecast FAQ

In the current month, MTVA has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MTVA average analyst price target in the past 3 months is $132.00.

  • Where Will MetaVia, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that MetaVia, Inc. share price will rise to $132.00 per share over the next 12 months.

  • What Do Analysts Say About MetaVia, Inc.?

    Analysts are divided on their view about MetaVia, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MetaVia, Inc. is a Sell and believe this share price will drop from its current level to $55.00.

  • What Is MetaVia, Inc.'s Price Target?

    The price target for MetaVia, Inc. over the next 1-year time period is forecast to be $132.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MTVA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for MetaVia, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of MTVA?

    You can purchase shares of MetaVia, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MetaVia, Inc. shares.

  • What Is The MetaVia, Inc. Share Price Today?

    MetaVia, Inc. was last trading at $9.59 per share. This represents the most recent stock quote for MetaVia, Inc.. Yesterday, MetaVia, Inc. closed at $9.31 per share.

  • How To Buy MetaVia, Inc. Stock Online?

    In order to purchase MetaVia, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
73
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 39x

Alerts

Buy
80
FEIM alert for Dec 13

Frequency Electronics, Inc. [FEIM] is up 28.76% over the past day.

Buy
57
MOD alert for Dec 13

Modine Manufacturing Co. [MOD] is down 15.32% over the past day.

Sell
42
OKLO alert for Dec 13

Oklo, Inc. [OKLO] is down 14.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock